UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assessing the need for psychooncological support: screening instruments in combination with patients' subjective evaluation may define psychooncological pathways

Psycho-oncology (Chichester, England), 2015-12, Vol.24 (12), p.1784-1791

2015

Volltextzugriff (PDF)

Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease

Gynecologic oncology, 2019-04, Vol.153 (1), p.49-54

2019

Volltextzugriff (PDF)

Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial

Gynecologic oncology, 2017-08, Vol.146 (2), p.279-284

2017

Volltextzugriff (PDF)

Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse

Annals of oncology, 2015-06, Vol.26 (6), p.1155-1160

2015

Volltextzugriff (PDF)

Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?

Journal of cancer research and clinical oncology, 2016-08, Vol.142 (8), p.1847-1853

2016

Volltextzugriff (PDF)

COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy

ESMO open, 2022-12, Vol.7 (6), p.100637, Article 100637

2022

Volltextzugriff (PDF)

Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer

Technology in cancer research & treatment, 2023-01, Vol.22, p.15330338231164537-15330338231164537

2023

Volltextzugriff (PDF)

Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

Breast (Edinburgh), 2020-12, Vol.54, p.88-95

2020

Volltextzugriff (PDF)

Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma

BMC cancer, 2011-01, Vol.11 (1), p.42-42, Article 42

2011

Volltextzugriff (PDF)

Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

BMC cancer, 2020-11, Vol.20 (1), p.1091-1091, Article 1091

2020

Volltextzugriff (PDF)

Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality

JNCI : Journal of the National Cancer Institute, 2016-06, Vol.108 (6), p.djv428-djv428

2016

Volltextzugriff (PDF)

Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study

BMC cancer, 2019-06, Vol.19 (1), p.611-611, Article 611

2019

Volltextzugriff (PDF)

Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies

Gynecologic oncology, 2009-03, Vol.112 (3), p.605-609

2009

Volltextzugriff (PDF)

Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression

Annals of oncology, 2014-08, Vol.25 (8), p.1551-1557

2014

Volltextzugriff (PDF)

Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer

Anticancer research, 2013-05, Vol.33 (5), p.2233-2238

2013

Volltextzugriff (PDF)

Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial

Breast (Edinburgh), 2012-02, Vol.21 (1), p.27-33

2012

Volltextzugriff (PDF)

Time trends of neoadjuvant chemotherapy for early breast cancer

International journal of cancer, 2020-12, Vol.147 (11), p.3049-3058

2020

Volltextzugriff (PDF)

Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer

Anticancer research, 2023-04, Vol.43 (4), p.1449-1454

2023

Volltextzugriff (PDF)

Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients

Annals of oncology, 2018-01, Vol.29 (1), p.186-192

2018

Volltextzugriff (PDF)

COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy

Annals of oncology, 2014-02, Vol.25 (2), p.372-377

2014

Volltextzugriff (PDF)

Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program

ESMO open, 2021-12, Vol.6 (6), p.100299-100299, Article 100299

2021

Volltextzugriff (PDF)

Cut-Off Analysis of CTC Change under Systemic Therapy for Defining Early Therapy Response in Metastatic Breast Cancer

Cancers, 2020-04, Vol.12 (4), p.1055

2020

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBreast Cancer Research And Treatment

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(74)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(9)
European Journal Of Cancer
(7)
Anticancer Research
(6)
Gynecologic Oncology
(6)
Journal Of Cancer Research And Clinical Oncology
(6)
Bmc Cancer
(5)
Cancer Research
(4)
Breast
(3)
British Journal Of Cancer
(2)
Cancers
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Assessing the need for psychooncological support: screening instruments in combination with patients' subjective evaluation may define psychooncological pathways

Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease

Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial

Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse

Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?

COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy

Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer

Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma

Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality

Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study

Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies

Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression

Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer

Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial

Time trends of neoadjuvant chemotherapy for early breast cancer

Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study

Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics – A retrospective analysis of a real world registry

Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer

Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients

COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy

Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program

Cut-Off Analysis of CTC Change under Systemic Therapy for Defining Early Therapy Response in Metastatic Breast Cancer

Aktive Filter

Suchergebnisse filtern